Provided by Tiger Fintech (Singapore) Pte. Ltd.

Crinetics Pharmaceuticals Inc.

31.20
-0.5700-1.79%
Post-market: 31.200.00000.00%17:24 EDT
Volume:533.61K
Turnover:16.64M
Market Cap:2.92B
PE:-8.17
High:32.00
Open:32.00
Low:30.94
Close:31.77
Loading ...
Aug 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2020

Major Issues Report

8-K - Current report
Jun 22, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 08, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 15, 2020

Major Issues Report

8-K - Current report
Apr 14, 2020

Major Issues Report

8-K - Current report
Apr 06, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Mar 09, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01